Great Valley Advisor Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,084
Closed -$618K 1012
2025
Q4
$618K Hold
6,084
0.01% 576
2025
Q3
$333K Sell
6,084
-20
-0.3% -$999 0.01% 741
2025
Q2
$325K Sell
6,104
-100
-2% -$5.08K 0.01% 723
2025
Q1
$268K Sell
6,204
-1,023
-14% -$51.8K 0.01% 756
2024
Q4
$406K Sell
7,227
-1,307
-15% -$81.3K 0.01% 618
2024
Q3
$581K Sell
8,534
-157
-2% -$8.86K 0.01% 529
2024
Q2
$367K Buy
8,691
+132
+2% +$7.26K 0.01% 604
2024
Q1
$591K Buy
8,559
+1,475
+21% +$93.3K 0.02% 456
2023
Q4
$524K Buy
7,084
+4
+0.1% +$262 0.02% 447
2023
Q3
$483K Sell
7,080
-1
-0% -$85 0.02% 444
2023
Q2
$665K Sell
7,081
-572
-7% -$44.6K 0.03% 386
2023
Q1
$519K Sell
7,653
-250
-3% -$16.1K 0.02% 429
2022
Q4
$391K Sell
7,903
-385
-5% -$15.7K 0.02% 488
2022
Q3
$269K Sell
8,288
-1
-0% -$41 0.02% 557
2022
Q2
$327K Sell
8,289
-317
-4% -$17K 0.02% 528
2022
Q1
$602K Sell
8,606
-573
-6% -$41.9K 0.04% 360
2021
Q4
$714K Sell
9,179
-21,590
-70% -$1.91M 0.04% 318
2021
Q3
$2.94M Buy
30,769
+8,200
+36% +$866K 0.2% 128
2021
Q2
$2.81M Buy
22,569
+792
+4% +$94.5K 0.21% 127
2021
Q1
$2.87M Buy
21,777
+1,837
+9% +$251K 0.28% 89
2020
Q4
$2.64M Sell
19,940
-979
-5% -$118K 0.27% 86
2020
Q3
$2.13M Sell
20,919
-2,301
-10% -$199K 0.26% 85
2020
Q2
$2.02M Sell
23,220
-2,308
-9% -$184K 0.33% 82
2020
Q1
$1.48M Buy
25,528
+3,217
+14% +$261K 0.39% 79
2019
Q4
$2.06M Buy
22,311
+5,699
+34% +$501K 0.46% 69
2019
Q3
$1.5M Buy
16,612
+4,554
+38% +$519K 0.36% 85
2019
Q2
$1.42M Buy
12,058
+2,929
+32% +$295K 0.36% 89
2019
Q1
$791K Buy
9,129
+4,203
+85% +$358K 0.25% 117
2018
Q4
$311K Buy
+4,926
New +$338K 0.12% 158

Other funds holding EXAS

Great Valley Advisor Group's EXAS Position: Q1 2026 in Review

Great Valley Advisor Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 6,084 shares — an estimated $618K sold.

Great Valley Advisor Group first reported a position in EXAS in Q4 2018 and held it in 29 quarters. The position peaked at $2.94M in Q3 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Great Valley Advisor Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Great Valley Advisor Group sold 6,084 Exact Sciences shares in Q1 2026, an estimated $618K.
  • Great Valley Advisor Group first reported a position in Exact Sciences in Q4 2018 and held it in 29 quarters.
  • Great Valley Advisor Group's Exact Sciences position peaked at $2.94M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Great Valley Advisor Group's 13F filing for Q1 2026, filed 11 May 2026.